Screener
Repligen RGEN Concentration Risk %
Concentration Risk % at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Repligen in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The source filing: Repligen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323773
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue by customers' geographic locations: | ||||
| North America | 51% | 49% | 48% | 49% |
| Europe | 32% | 38% | 35% | 36% |
| Asia Pacific ("APAC") & Rest of World (1) | 17% | 13% | 17% | 15% |
| Total revenue | 100% | 100% | 100% | 100% |
ITEM 1. Financial Statements
FAQ
- What is Repligen's concentration risk %?
- Repligen (RGEN) reported concentration risk % of 100% in Q2 2026.
- How has Repligen's concentration risk % changed year-over-year?
- Repligen's concentration risk % decreased by 0.0% year-over-year, from 100% to 100%.
Ask your AI about Repligen's concentration risk %.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude